Search

everythinglearnresearchcommunity

for

Search:↓

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

SIM01 significantly reduced post-COVID symptoms and is safe.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Long-lasting symptoms like fatigue and breathlessness can persist after COVID-19, requiring ongoing medical follow-up.

Kampo medicine can help treat general fatigue from long COVID.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

COVID-19 infection may cause hair loss.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Shi-Bi-Man, a Traditional Chinese Medicine, helps grow hair by boosting lactic acid metabolism and activating hair follicle stem cells.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

New understanding and treatments for hair loss are improving, but more research is needed.

Minoxidil patches and cold plasma may help treat hair loss.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.